Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Immuno Cure kick off Phase I Clinical Trial in Shenzhen
2023-02-16 20:36
Oral Presentation at APASL Annual Meeting 2023 Demonstrates ASC22, a Subcutaneous PD-L1 Antibody, Can Achieve Functional Cure of Chronic Hepatitis B
2023-02-16 17:10
Aqilion announces pre-clinical licensing and strategic research collaboration agreement with Merck
2023-02-16 15:00
Pharming provides update on EMA regulatory review of leniolisib for APDS in Europe
2023-02-16 14:00
Boan Biotech's Investigational Long-acting Anti-IL-4Rα Antibody BA2101 Administered for First Patient in Phase I Clinical Trial
2023-02-16 08:15
Innovent Announces First Patient Dosed in a Phase 3 Clinical Trial (CLEAR) of Picankibart (Anti-IL23p19 Monoclonal Antibody) in Patients with Moderate-to-Severe Plaque Psoriasis
2023-02-16 08:00
Tetracore Announces USDA Purchase of ASF and FMD Diagnostic Test Kits
2023-02-16 04:35
Bioved Pharmaceuticals, Inc. announces the launch of its proprietary Natural Products for Animal Health, with its Shwan Ayurved™ science
2023-02-16 01:00
Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Initiation of Phase II Study of naronapride in patients with gastroparesis
2023-02-15 21:30
Internationally Renowned Orthopaedic Surgeon Thought Leaders Join Formus Labs' Clinical Advisory Board
2023-02-15 21:00
Kubota Tractor Corporation Implements Syncron For Streamlined Retail Inventory Management and Exceptional Dealer Network Service
2023-02-15 21:00
Flagship Biosciences Applauded by Frost & Sullivan for Changing Biomarker Analysis to Find Biomarkers that Aid Drug Development and Diagnostics
2023-02-15 21:00
Henlius Announces U.S. FDA Acceptance of Biologics License Application for Proposed Biosimilar Trastuzumab HLX02
2023-02-15 16:49
Mindray Revolutionizes the Way of Using Ultrasound with TE Air, Its First Wireless Handheld Ultrasound System
2023-02-15 14:40
GILEAD TO PRESENT DATA AT APASL 2023 ON EFFECTIVE MODELS FOR MONITORING AND TREATING HEPATITIS C AND EFFICACY OF ANTIVIRAL TREATMENTS FOR HIV-1 AND HBV-COINFECTED ADULTS
2023-02-15 10:00
Innovent Announces First Participant Dosed in Phase 2 Study of IBI311 (Anti-IGF-1R Monoclonal Antibody) in Patients with Thyroid Associated Ophthalmopathy
2023-02-15 08:00
Groundbreaking clinical trial underway to improve vision in individuals with advanced Retinitis Pigmentosa (RP)
2023-02-15 05:10
Telix Collaboration on Next Generation Urologic-Oncology Theranostic Published in Journal of Nuclear Medicine
2023-02-15 04:51
Eurofins Discovery Collaborating with Invasight on Cancer Therapies
2023-02-15 00:10
CJ Biomaterials Teams with Banila Co. to Develop New 100% Biobased Cosmetic Jar using Amorphous PHA
2023-02-14 22:00
1
131
132
133
134
135
533